MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-TS-02-0021768
Scikem Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹20.26 Cr
▼ 43% YoY
Net profit · FY 2024
₹32.47 Lakh
Net margin 1.6%
EBITDA · FY 2024
₹50.63 Lakh
EBITDA margin 2.5%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Scikem Pharmaceuticals Private Limited
Data last updated:
Scikem Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24299TG2017PTC115917. Its GSTIN is 36AAYCS3382A1Z2 (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Raji Reddy Akiti and Pradeep Kumar Devulapalli.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No:11 – 6 – 24/5 Bala Nagar Kukatpally, Hyderabad, Telangana, India – 500042.
As per the financials filed for FY 2024, the company reported a revenue of ₹20.26 Cr, a decline of 43% compared to the previous year. For the same year it recorded a net profit of ₹32.47 Lakh (net margin 1.6%) and EBITDA of ₹50.63 Lakh (EBITDA margin 2.5%). Revenue has grown at a compounded annual rate (CAGR) of 36% over three years and 59% over five years.
Scikem Pharmaceuticals Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-TS-02-0021768). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website scikem.com.
Company details
CIN U24299TG2017PTC115917
Registration Number 115917
Incorporation Date 16 March 2017
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-TS-02-0021768
Recognitions & Rankings of Scikem Pharmaceuticals
Contact details
Scikem Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is scikem.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressH.No:11 – 6 – 24/5 Bala Nagar Kukatpally, Hyderabad, Telangana, India – 500042
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Scikem Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Scikem Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Scikem Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Scikem Pharmaceuticals Private Limited, buy the company report.
Financials of Scikem Pharmaceuticals Private Limited
FY 2025 filings availableScikem Pharmaceuticals Private Limited reported revenue of ₹20.26 Cr (down 43% YoY) for FY 2024.
Revenue · FY 2024
₹20.26 Cr ▼ 43%
Net profit · FY 2024
₹32.47 Lakh margin 1.6%
EBITDA · FY 2024
₹50.63 Lakh margin 2.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 43%
3 years · compounded
▲ 36%
5 years · compounded
▲ 59%
EBITDA CAGR growth
1 year
▼ 60%
3 years · compounded
▼ 15%
5 years · compounded
▲ 31%
Revenue fell 43% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 59%. EBITDA fell 60% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹50.63 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹32.47 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.5% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Scikem Pharmaceuticals Private Limited, buy the company report.
Board of directors of Scikem Pharmaceuticals Private Limited
Scikem Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raji Reddy Akiti | Director | 16 Mar 2017 | 9 Years 7 Months | Current |
| Pradeep Kumar Devulapalli Also directs: Dsksunrise Poultry Farms Private Limited | Director | 16 Mar 2017 | 9 Years 7 Months | Current |
Peer comparison
Scikem Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ariston Pharma Nova Tech Private Limited | ₹20.3 Cr (FY 2019) | -47.0% | Hyderabad, Telangana, India | |||
| Janya Biocare Private Limited | ₹20.29 Cr (FY 2025) | -19.0% | Roorkee, Uttarakhand, India | |||
| Scikem Pharmaceuticals Private Limitedthis company | ₹20.26 Cr (FY 2024) | ₹32.47 Lakh | 1.6% | -43.0% | Hyderabad, Telangana, India | |
| VSN Laboratories Private Limited | ₹20.26 Cr (FY 2023) | -7.0% | Hyderabad, Telangana, India | |||
| Ohad Pharmaceuticals Private Limited | ₹20.22 Cr (FY 2025) | 6.0% | Bharuch, Gujarat, India | |||
| Anmol Chemicals and Pharmaceuticals Private Limited | ₹20.18 Cr (FY 2024) | 315.0% | Mumbai, Maharashtra, India | |||
| Standard Pharmaceuticals Ltd | ₹20.17 Cr (FY 2025) | 38.0% | Kolkata, West Bengal, India | |||
| Biocenna Healthcare Private Limited | ₹20.13 Cr (FY 2025) | 125.0% | Deoband, Uttar Pradesh, India |
To see the full peer comparison of Scikem Pharmaceuticals Private Limited, buy the company report.
Auditor
Scikem Pharmaceuticals Private Limited is audited by T M C S AND ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| T M C S AND ASSOCIATES | FY 2021 | 017279S |
Shareholding
The shareholding of Scikem Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Scikem Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Scikem Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Scikem Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Scikem Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAYCS3382A1Z2 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Scikem Pharmaceuticals Private Limited, buy the company report.
Recent activity
Scikem Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Pradeep Kumar Devulapalli was appointed as Director on 16 Mar 2017.
AGM
Scikem Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Scikem Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Pradeep Kumar Devulapalli was appointed as Director.
Appointed
Raji Reddy Akiti was appointed as Director.
Incorporation
16 Mar 2017
Scikem Pharmaceuticals Private Limited was registered on 16 Mar 2017 with Roc Hyderabad & aged 9 years 7 months as per MCA records.
Frequently asked questions
Scikem Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 March 2017 (9+ years old) and is registered under CIN U24299TG2017PTC115917.
Scikem Pharmaceuticals has 2 current directors:
- Raji Reddy Akiti - Director
- Pradeep Kumar Devulapalli - Director
The latest financial statements of Scikem Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Scikem Pharmaceuticals is 36AAYCS3382A1Z2, registered in Telangana.
The CIN (Corporate Identification Number) of Scikem Pharmaceuticals is U24299TG2017PTC115917. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Scikem Pharmaceuticals was incorporated on 16 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Scikem Pharmaceuticals by revenue are Ariston Pharma Nova Tech Private Limited, Janya Biocare Private Limited, VSN Laboratories Private Limited, Ohad Pharmaceuticals Private Limited, Anmol Chemicals and Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Pradeep Kumar Devulapalli was appointed as Director on 16 Mar 2017. Raji Reddy Akiti was appointed as Director on 16 Mar 2017.
Yes, Scikem Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-TS-02-0021768).
Scikem Pharmaceuticals can be reached through the website scikem.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Scikem Pharmaceuticals is at H.No:11 – 6 – 245 Bala Nagar Kukatpally, Hyderabad, Telangana, India – 500042.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages